Latest McGill University Health Centre Stories
A team of researchers from McGill/MUHC validates a novel screening tool in the fight against Chagas disease.
A new study has found that Vitamin D, readily available in supplements or cod liver oil, can counter the effects of Crohn's disease.
Canadian teenagers are among the largest consumers of cannabis worldwide.
Researchers at the MUHC and their international colleagues have identified the first genetic resistance factor against tuberculosis infection.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colors.
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
MUHC researchers link smoking to skin problems in people with SLE.
A team of researchers at the MUHC/McGill and their international colleagues recommend halting all clinical trials on interleukin-2.
Researchers at MUHC/McGill uncover key role played by a molecule in the process of infection used by the parasite that causes leishmania.
Tuberculosis is a global threat that affects more than 10 million people each year. Working with colleagues in the United States and France, Dr. Dick Menzies of the Research Institute of the McGill University Health Centre (RI-MUHC) has placed current tuberculosis treatment guidelines under the microscope in a new study.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.